VuCOMP Announces Milestone for Development of Computer-Aided Detection for Breast Tomosynthesis

Published on:

Plano, TX (June 24, 2015) — VuCOMP, Inc., leading developer of advanced computer vision systems for the detection of breast cancer, is pleased to announce the successful completion of the development of structured reporting (SR) for CAD marks for digital breast tomosynthesis images. 

With this feature, VuCOMP has added the tomosynthesis slice information into the SR so that workstations will have the ability to display the CAD marks directly on the tomosynthesis slices.  Additionally, tomosynthesis findings will be shown as enhanced marks on the 2D images.

VuCOMP is working closely with the workstation vendors to continue to enhance the integration process. 

This feature will be made available as part of VuCOMP’s M-Vu CAD System for breast tomosynthesis.   The M-Vu CAD system for breast tomosynthesis is currently under review by the Food and Drug Administration (FDA), pending approval.

Jim Pike, President and CTO of VuCOMP stated, “Integration of our CAD markings on tomosynthesis images via the various workstations currently deployed is a major milestone in our development of the first commercially available CAD solution for digital breast tomosynthesis. The SR output is a critical step as we continue to progress down the development path.  It has been important for us to work out the details of displaying marks on tomosynthesis slices so that once the FDA approves a CAD system for tomosynthesis, we will have a mechanism in place for appropriate display on the slices.”

The M-Vu® CAD system was the first mammography CAD product to meet the rigorous FDA standard that recommends comprehensive reader studies to prove the effectiveness of CAD systems. VuCOMP continues to provide systematic product updates, fulfilling the company’s commitment to ongoing enhancements for its customers.

About VuCOMP, Inc.
VuCOMP, Inc. leads the way in setting a new standard for CAD. The company is dedicated exclusively to developing advanced cancer detecting technologies. VuCOMP’s engineering team has worked together since 1986, pioneering some of the world’s most advanced computer vision systems.  For more information, please visit www.vucomp.com.

 

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.